Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PRQR compared with IMUX: revenue, margins and what each company keeps, and the suppliers and customers both name
PRQR
ProQR Therapeutics N.V.
Change
Mkt cap
Revenue
Revenue
IMUX
Immunic, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PRQR
ProQR Therapeutics N.V.
vs
IMUX
Immunic, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PRQR, solid
IMUX, dashed
Supply-chain overlap
Revenue flow
PRQR: latest quarter not drawable. IMUX: latest quarter not drawable.
Method
›
PRQR
ProQR Therapeutics N.V.
Change
1.38
▼
−4.31%
· post 1.43
Mkt cap
$146.5M
IMUX
Immunic, Inc.
Change
7.53
▼
−3.42%
· post 7.53
Closed
Oct 30 '26
Mkt cap
$102.5M
vs
Compare
Closed
Oct 30 '26
PRQR
ProQR Therapeutics N.V.
vs
IMUX
Immunic, Inc.
1.38
▼
−4.31%
post 1.43
Price
7.53
▼
−3.42%
post 7.53
$146.5M
Mkt cap
$102.5M
Change
Change
PRQR
1.38
▼
−4.31%
vs
IMUX
7.53
▼
−3.42%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PRQR
1
LLY
Eli Lilly
customer
Shared
0
No shared counterparties.
Only IMUX
7
—
Daiichi Sankyo
unlisted
supplier
—
4SC
unlisted
supplier
—
Fraunhofer Institute
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
German Federal Ministry of Finance
unlisted
supplier
3 more · IMUX chain
›